Finance

Lists
Why is 4570 down 5,09%?
Dive Deeper
4570:TYO
Immuno-Biological Laboratories Co., Ltd.
1 062,00 JP¥
-5,09%
(-57,00) 1D
8 қаз., 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4570...
Open
1 111 JP¥
High
1 111 JP¥
Low
1 049 JP¥
Mkt. cap
9,78 млрд
Avg. vol.
148,64 м.
Volume
166,30 м.
Dividend
0,56%
Quarterly dividend
1 JP¥
Ex-dividend date
2026 ж. 30 нау.
P/E ratio
26,85
52-wk high
3 820 JP¥
52-wk low
464 JP¥
EPS
40 JP¥
Shares outstanding
8,42 млн
No. of employees
54
Open
1 111 JP¥
High
1 111 JP¥
Low
1 049 JP¥
Mkt. cap
9,78 млрд
Avg. vol.
148,64 м.
Volume
166,30 м.
Dividend
0,56%
Quarterly dividend
1 JP¥
Ex-dividend date
2026 ж. 30 нау.
P/E ratio
26,85
52-wk high
3 820 JP¥
52-wk low
464 JP¥
EPS
40 JP¥
Shares outstanding
8,42 млн
No. of employees
54
News stories
From web sources and news partners
Bloomberg Law News
Bloomberg Law News
·
10 минут бұрын
Nasdaq-Listed Lobbying Firm Launches Capitol Hill Oversight Unit
www.marketscreener.com
www.marketscreener.com
·
11 минут бұрын
Kyivstar to Report 3Q26 Results on November 6, 2026
Simply Wall Street
Simply Wall Street
·
36 минут бұрын
Comcast Partnership Could Be A Turning Point For Fastly (FSLY)
Yahoo Finance
Yahoo Finance
·
1 сағат бұрын
Prediction: The S&P 500 Will Hit 10,000 in 2027
About Immuno-Biological Laboratories Co., Ltd.
CEO-
Employees54
Founded1982 ж. 09 қыр.
Headquarters-
Sector-
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
274,00 млн
257,00 млн
262,00 млн
286,00 млн
Cost of goods sold
85,00 млн
65,00 млн
88,00 млн
64,00 млн
Cost of revenue
85,00 млн
65,00 млн
88,00 млн
64,00 млн
Research and development expenses
-
-
120,00 млн
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
101,00 млн
110,00 млн
-9,00 млн
104,00 млн
Operating expense
101,00 млн
110,00 млн
117,00 млн
104,00 млн
Total operating expenses
186,00 млн
175,00 млн
205,00 млн
168,00 млн
Operating income
88,00 млн
82,00 млн
57,00 млн
118,00 млн
Other non operating income
2,00 млн
1,00 млн
6,00 млн
-
EBT including unusual items
92,00 млн
87,00 млн
65,00 млн
108,00 млн
EBT excluding unusual items
92,00 млн
87,00 млн
65,00 млн
119,00 млн
Income tax expense
11,00 млн
-20,00 млн
-16,00 млн
8,00 млн
Effective tax rate
11,96%
-22,99%
-24,62%
7,41%
Other operating expenses
-
-
-
-
Net income
81,00 млн
107,00 млн
81,00 млн
100,00 млн
Net profit margin
29,56%
41,63%
30,92%
34,97%
Earnings per share
-
-
-
-
Interest and investment income
-
-
1,00 млн
-
Interest expense
-
-1,00 млн
-
-
Net interest expenses
-
-1,00 млн
1,00 млн
-
Depreciation and amortization charges
-
-
6,00 млн
-
EBITDA
92,00 млн
85,75 млн
61,50 млн
122,50 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары